Strain Profile
Save

Weissella cibaria CMS1

◐ Food-origin
Sequenced
Public genome assembly available

Weissella cibaria CMS1 is an oral probiotic strain with early-stage evidence across a small number of studies. A 2006 randomized controlled trial examined CMS1's activity against Streptococcus mutans biofilm formation in a clinical setting; S. mutans is a bacterium associated with dental plaque. In vitro work has examined CMS1's activity against certain respiratory viruses and rotavirus under laboratory conditions. Animal model research has examined the strain, in combination with a related Weissella strain, in the context of allergic airway inflammation. These findings are preliminary and do not establish clinical efficacy; the strain remains an early-research-stage candidate. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 3 body-system-tagged papers that concern each system. Research coverage, not measured effect.

Symptoms in the research

Share of this strain's 2 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

Research

3 papers reference this strain in the probiotic database.

Match confidence
Browse all 3 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    In Vitro Inactivation of Respiratory Viruses and Rotavirus by the Oral Probiotic Strain Weissella cibaria CMS1
    · Probiotics and Antimicrobial Proteins · 2022
    PMID 35536505 →
  2. [2]
    Therapeutic Efficacy of Weissella cibaria CMU and CMS1 on Allergic Inflammation Exacerbated by Diesel Exhaust Particulate Matter in a Murine Asthma Model
    · Medicina · 2022
    PMID 36143987 →
  3. [3]
    Effect of Weissella cibaria Isolates on the Formation of Streptococcus mutans Biofilm
    · Caries Research · 2006
    PMID 16946611 →